Structure of Urolithin A
CAS No.: 1143-70-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Urolithin A is a metabolite of ellagitannin with antiproliferative and antioxidant properties. It can cross the blood brain barrier, and may have neuroprotective effects against Alzheimer’s Disease. Urolithin A has been shown to stimulate mitophagy and improve muscle function in aged animals15 and in models of muscular dystrophy,16 while also being safe, bioavailable, and able to induce mitochondrial gene expression in older adults.
Synonyms: 2',7-Dihydroxy-3,4-benzocoumarin; 3,8-Dihydroxy Urolithin
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Heyns, Ingrid Marie ; Ganugula, Raghu ; Kumar, MNV Ravi ; Arora, Meenakshi ;
Abstract: In the past decade, liquid chromatography−mass spectrometry (LC-MS/MS) has become pivotal in clinical diagnosis, drug discovery, and bioanalytical science due to its high sensitivity and rapid analysis. We have developed an ultrasensitive and robust LC-MS/MS method for the simultaneous detection and quantification of cyclosporine A (CsA) and urolithin A (UA) employing ascomycin (ASC) and naringenin (NAR) as internal standards (ISTDs). The method was validated for clinical use, revealing interspecies differences between human plasma and other mammals (e.g., mouse, rat, feline, canine, and bovine serum). Validation parameters, including accuracy, precision, limits of quantification, specificity, selectivity, carryover, linearity, stability, and recovery, met acceptable ICH standards. Linear regression across the full calibration range (1−250 ng/mL for CsA and 0.5−125 ng/mL for UA) yielded an average R2 ≥ 0.999 in all mammal models. The method achieved a limit of quantification (LOQ) of 1−2.5 ng/mL across all model plasma samples with negligible carryover and demonstrated sample stability up to 96 h intra- and interday and 48 h for bovine serum. The method was successfully applied to quantify CsA and UA in canine samples following oral administration from a previous study. With a rapid run time of 6 min, this method offers high selectivity and precision, making it ideal for analyzing limited sample sizes and addressing regulatory challenges. The ability to simultaneously quantify CsA and UA has significant clinical potential for managing complex immuno-inflammatory diseases, enabling precise dose adjustments, and optimizing treatment outcomes.
Show More >
| CAS No. : | 1143-70-0 |
| Formula : | C13H8O4 |
| M.W : | 228.20 |
| SMILES Code : | O=C1C2=CC(O)=CC=C2C3=C(O1)C=C(O)C=C3 |
| Synonyms : |
2',7-Dihydroxy-3,4-benzocoumarin; 3,8-Dihydroxy Urolithin
|
| MDL No. : | MFCD20275235 |
| InChI Key : | RIUPLDUFZCXCHM-UHFFFAOYSA-N |
| Pubchem ID : | 5488186 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H302 |
| Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| HEK293 APP-Swedish cells | 30 μM | To evaluate the effect of UA on Aβ42 expression in HEK293 APP-Swedish cells, it was found that UA decreased Aβ42 expression. | Alzheimers Dement. 2024 Jun;20(6):4212-4233. | |
| HMC3 human microglia cells | 30 μM | 48 hours | To evaluate the effect of UA on IL-1β expression in HMC3 cells, it was found that UA significantly reduced IL-1β expression, and this effect was partially dependent on CTSZ. | Alzheimers Dement. 2024 Jun;20(6):4212-4233. |
| SH-SY5Y cells | 100 nM | 24-48 h | Urolithin A pretreatment significantly inhibited high glucose-induced mitochondrial calcium accumulation, indicating its regulatory effect on high glucose-induced mitochondrial calcium homeostasis. | Cell Death Differ. 2021 Jan;28(1):184-202. |
| SH-SY5Y cells | 100 nM | 48 h | Urolithin A pretreatment significantly reduced high glucose-induced mtROS levels, indicating its inhibitory effect on high glucose-induced oxidative stress. | Cell Death Differ. 2021 Jan;28(1):184-202. |
| SH-SY5Y cells | 100 nM | 72 h | Urolithin A significantly reduced high glucose-induced LDH release, indicating its protective effect against high glucose-induced cell damage. | Cell Death Differ. 2021 Jan;28(1):184-202. |
| HEK293 APP-Swedish cells | 30 μM | 48 h | To investigate the effect of Urolithin A on Aβ42 expression in HEK293 APP-Swedish cells, results showed that UA decreased Aβ42 expression. | Alzheimers Dement. 2024 Jun;20(6):4212-4233. |
| HMC3 human microglia cells | 30 μM | 48 h | To investigate the effect of Urolithin A on Aβ42-induced inflammatory response in HMC3 cells, results showed that UA significantly reduced IL-1β expression. | Alzheimers Dement. 2024 Jun;20(6):4212-4233. |
| ARPE-19 cells | 100 μM | 24 h | UA restored viability in SI-treated ARPE-19 cells and reduced 4-HNE levels, indicating that UA maintained proteostasis by restoring autophagic flux. | Mol Neurodegener. 2024 Jun 18;19(1):49. |
| HepG2 cells | 20 μM | 24 h | To validate the role of MUP1 in UA-mediated alleviation of alcohol-induced ER stress, results showed that knockdown of MUP1 attenuated the beneficial effects of UA on ER stress-related proteins. | Gut Microbes. 2024 Jan-Dec;16(1):2367342. |
| BMDMs | 5, 10, 25, 50 µM | 24 h | To observe the effect of UA on BMDMs cell activity and inflammatory factors, it was found that UA treatment inhibited CM stimulation-induced elevated mRNA expression of IL-6 and TNF-α and decreased extracellular secretion of IL-6. | J Adv Res. 2025 Mar;69:125-138. |
| THP-1 | 5, 10, 25, 50 µM | 24 h | To observe the effect of UA on THP-1 cell activity and inflammatory factors, it was found that UA treatment inhibited CM stimulation-induced elevated mRNA expression of IL-6 and TNF-α and decreased extracellular secretion of IL-6. | J Adv Res. 2025 Mar;69:125-138. |
| Th17 cells | 5 µM | 4 h | URA significantly inhibited the differentiation of CD4+ T cells into Th17 cells, reduced IL-17 secretion, and decreased the expression of Th17-related genes. | EBioMedicine. 2021 Feb;64:103227. |
| Bone marrow-derived dendritic cells (BM-DCs) | 25 µM | 18 h | URA inhibited the activation of BM-DCs, reduced the expression of co-stimulatory molecules CD80, CD86, and MHCII, and suppressed the secretion of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, while increasing the expression of anti-inflammatory cytokine IL-10. | EBioMedicine. 2021 Feb;64:103227. |
| primary mouse cardiomyocytes | 10 μg/mL | 6 h | To evaluate the protective effect of UA on LPS-induced cardiomyocyte injury, the results showed that UA significantly improved cell viability and alleviated LPS-induced cardiomyocyte injury. | MedComm (2020). 2023 Dec 19;4(6):e459. |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| Mice | APP/PS1 mice, 3xTgAD mice, 3xTgAD/Pol β+/− mice | Oral gavage | 200 mg/kg/day | Once daily for 5 months | To evaluate the effects of long-term UA treatment on cognitive function, olfactory function, synaptic function, Aβ and tau pathology, neuroinflammation, lysosomal function, and DNA damage in AD mice. The results showed that UA significantly improved learning, memory, and olfactory function in AD mice, reduced Aβ and tau pathologies, enhanced long-term potentiation, and induced mitophagy by increasing lysosomal functions. | Alzheimers Dement. 2024 Jun;20(6):4212-4233. |
| Mice | STZ-induced diabetic mouse model | Intraperitoneal injection | 2.5 mg/kg | Once daily for 8 weeks | Urolithin A injection significantly inhibited STZ-induced expression of APP, BACE1, and p-Tau, as well as Aβ deposition, indicating its protective effect against diabetes-associated Alzheimer's disease pathology. | Cell Death Differ. 2021 Jan;28(1):184-202. |
| Mice | APP/PS1 mice, 3xTgAD mice, 3xTgAD/Pol β+/− mice | Oral gavage | 200 mg/kg | Once daily for 5 months | To investigate the effect of long-term Urolithin A treatment on learning and memory in Alzheimer's disease mouse models, results showed that UA significantly improved learning and memory and reduced Aβ and tau pathologies. | Alzheimers Dement. 2024 Jun;20(6):4212-4233. |
| Mice | C57BL/6J wild-type mice | Intraperitoneal injection | 2.3 mg/kg | Daily for 7 days | UA alleviated SI-induced neurodegeneration and preserved visual function. UA restored autophagic flux and triggered PINK1/Parkin-dependent mitophagy. | Mol Neurodegener. 2024 Jun 18;19(1):49. |
| C57BL/6J mice | Chronic alcohol-induced liver disease model | Oral gavage | 200 mg/kg | Daily for 14 weeks | UA alleviated chronic alcohol-induced liver disease by modulating the gut-microbiota-liver axis, significantly improving alcohol-induced metabolic disorders and hepatic ER stress, and restoring gut microbiota dysbiosis. | Gut Microbes. 2024 Jan-Dec;16(1):2367342. |
| BALB/c mice | Breast cancer xenograft model | Dietary administration | 2 g/kg | Two weeks | To observe the effect of UA on the breast cancer xenograft model, it was found that UA treatment significantly reduced tumor size and decreased IL-6 levels in the tumor environment. | J Adv Res. 2025 Mar;69:125-138. |
| C57BL/6 mice | Experimental autoimmune encephalomyelitis (EAE) model | Oral | 25 mg/kg | Daily administration until the end of the experiment (30 days) | URA significantly alleviated the clinical symptoms of EAE mice, reduced inflammatory cell infiltration and demyelination in the central nervous system, and decreased the numbers of M1-type microglia and activated dendritic cells, while also reducing the infiltration of Th1/Th17 cells. | EBioMedicine. 2021 Feb;64:103227. |
| C57BL/6 mice | Severe acute pancreatitis-associated acute cardiac injury (SACI) model | Intraperitoneal injection | 30 mg/kg | 1 hour before and 3 hours after modeling, lasting for 24 hours | To investigate the cardioprotective effect of UA on SACI mice and its mechanisms, the results showed that UA significantly reduced serum levels of amylase, lipase, LDH, CK-MB, BNP, cTnT, cTnI, alleviated pathological damage to pancreatic and cardiac tissues, and reduced myocardial cell apoptosis and oxidative stress. | MedComm (2020). 2023 Dec 19;4(6):e459. |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.38mL 0.88mL 0.44mL |
21.91mL 4.38mL 2.19mL |
43.82mL 8.76mL 4.38mL |
|
Tags: Urolithin A | Drug Metabolite | Reactive Oxygen Species | DNA/RNA Synthesis | Autophagy | Apoptosis | Endogenous Metabolite | DNA synthesis inhibition | cell cycle progression | 1143-70-0
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


